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Monosomy 12 and deletion of 13q34 in a case of chronic lymphocytic
leukemia with concomitant lung cancer
Monozomija 12 i delecija 13q34 kod bolesnika sa hroničnom limfocitnom
leukemijom i istovremenim karcinomom pluća
Darko Antić, Marija Denčić-Fekete, Dragica Tomin, Irena Djunić
Clinical Center of Serbia, Clinic for Hematology, Belgrade, Serbia
Abstract
Background. We described a patient with chronic lympho-
cytic leukemia (CLL) and lung cancer and unusual chromo-
somal aberrations. Case report. At the same time with the
diagnosis of B-cell CLL, squamocellular lung carcinoma di-
agnosis was established. Using interphase fluoresecence in
situ hybridization technique (FISH) we detected monosomy
12 and deletion of 13q34 occured in the same clone. One
month after the beginning of examination the patient died
unexpectedly during sleep immediately before we applied a
specific treatment for CLL or lung carcinoma. Conclusion.
Simultaneous occurrence of monosomy 12 and deletion of
13q34 in a patient with B-cell CLL has been described only
once before, but as a part of a complex karyotype. The
prognostic significance of these abnormalities remains un-
certain.
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Apstrakt
Uvod. U ovom radu opisali smo slučaj bolesnika sa B-
ćelijskom hroničnom limfocitnom leukemijom (HLL) i kar-
cinomom pluća kod koga je detektovana neuobičajena hro-
mozomska abnormalnost. Prikaz bolesnika. U isto vreme,
kada je kod bolesnika postavljena dijagnoza HLL, dijag-
nostikovan je i skvamocelularan karcinom pluća. Korišćen-
jem tehnike fluorescentne in situ hibridizacije (FISH) doka-
zano je postojanje monozomije 12 i delecije 13q34 u istom
klonu. Mesec dana nakon početka ispitivanja bolesnik je
iznenada umro u snu pre primene bilo kakvog terapijskog
modaliteta. Zaključak. Simultana pojava monozomije 12 i
delecije 13q34 kod bolesnika sa B-HLL do danas je ob-
javljena samo jednom i to kao deo kompleksnog patološkog
kariotipa. Prognostički značaj ovih aberacija još uvek je
nepoznat.
Ključne reči:
leukemija, b-ćelije, hronična; pluća, neoplazme;
hromosomi, aberacije.
Introduction
Chronic lymphocytic leukemia (CLL) is a disease with
variable clinical course. While some patients die within a
few months after diagnosis, others survive for more than a
decade.
Clinical staging systems are widely used and have been
proven to be of prognostic significance. Other independent
prognostic parameters are the absolute peripheral blood lym-
phocyte count, lymphocyte doubling time, bone marrow
histology and, not the least, the presence and the type of
chromosomal abnormalities 
1.
The most frequent aberrations are deletions in 13q, 11q,
or 17p and trisomy 12. The detection of del 17p or del 11q is
associated with poor risk, while del 13q as a sole abnormal-
ity is associated with good-risk disease 
2, 3.
Also, previous studies have indicated that patients with
CLL have an increased risk of subsequent cancer, in par-
ticular cancers of the skin and lung 
4.
Case report
A 69-year old man, nonsmoker, presented a two-months
history of fatigue and nocturnal sweating. Physical examina-
tion showed the presence of splenomegaly and cervical, ax-
illary and inguinal lymphoadenopathies. The blood count
showed: hemoglobin 15.6 g/dL, platelets 143 × 10
9/L, white
blood cells 160 × 10
9/L. The differential count showed neu-
trophils 3%, lymphocytes 96%, and monocytes 1%.
The diagnosis of CLL was confirmed by immunophe-
notypic analysis, performed on peripheral blood mononu-
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cell markers (CD19, CD22), the coexpression of CD5 and
CD23 and the absence of sIg, CD79b, FMC7 and CD38 ex-
pression. Cytogenetic study was performed on lymphoid
cells from peripheral blood. Unfortunately, no metaphases
were found on the prepared slides.
The bone marrow aspirate was hypercellular with 80%
infiltration by small lymphocytes. Trephine biopsy showed a
diffuse pattern of infiltration. According to Binet staging
system the patient was considered in the stage B. Ultrasonog-
raphy of the abdomen showed the enlarged spleen of 160 cm
with the accessory spleen 1.9 × 1.7 cm. Chest X-ray and
computed tomography (CT) of the chest showed infiltrate in
the hilar region of the right lung associated to multiple le-
sions in the pulmonary parenchyma. Transbronchial lung bi-
opsy was performed and the diagnosis of squamocellular
lung carcinoma was established. One month after the begin-
ning of examination the patient unexpectedly died during
sleep immediately before we applied a specific treatment for
CLL or lung carcinoma. Autopsy was not performed.
Conventional karyotyping was done on the peripheral
blood cell chromosome preparations by standard cytogenetic
techniques. This included overnight culture of cells in RPMI
1640 medium supplemented with 20% fetal calf serum, and
lipopolysaccharide (LPS) mitogen stimulation. Harvesting at
24 and 72 hours was accomplished using colchicine incuba-
tion for 40 minutes. The preparations were fixed with metha-
nol and acetic acid in ratio of 3 to 1. Cell suspensions were
dropped to air-dried clean slides. Conventional Giemsa tryp-
sin (GTG) banding and analysis were performed. Unfortu-
nately, no metaphases were found on the prepared slides.
The CLL FISH Probe Panel, consisting of Set 1, and
Set 2, was used (Vysis, Downers Grove, IL). Probe Set 1
contains Spectrum Orange LSI p53 probe (17p13.1) and
Spectrum Green, LSI ATM (11q22.3) probe. Probe Set 2 is
composed of Spectrum Orange D13S319 (13q14.3) probe,
Spectrum Aqua LSI13q34 (13q34) probe, and Spectrum
Green CEP 12 probe which contains the D12Z3 alpha satel-
lite sequence located at the centromere of chromosome 12.
The FISH procedure was performed on peripheral blood cell
chromosome preparations according to the manufacturer’s
instructions.
Two hundred nuclei were analyzed for each probe. The
cutoff value for positivity was >  10% for monosomies of
D13S319, 13q34, ATM and p53, and > 10% for trisomy 12.
The slides were examined using a Zeiss fluorescent mi-
croscope.
FISH analysis with the LSI ATM/p53 probes showed
normal FISH pattern in all the analyzed cells, suggesting that
deletions of both 11q22.3 and 17p13.1 regions were not pre-
sent (data not shown).
FISH analysis with the D13S319/13q34/CEP12 probes
showed an abnormal FISH pattern in the part of analyzed
cells. Approximately 70% of nuclei were positive for mono-
somy 12 and 15% of 200 nuclei were positive for monosomy
of 13q34 region. Nuclei with monosomy 12 and normal sig-
nal pattern for 13q14.3 and 13q34 were also detected (Figure
1), but monosomy for 13q34 locus was seen only in associa-
tion with monosomy 12 (Figure 2).
Fig. 1 – FISH result showing monosomy of 12 (labeled with
Spectrum Green) and a normal signal pattern for 13q14
(Spectrum Orange) and 13q34 (Spectrum Aqua)
Fig. 2 – FISH result showing monosomy of 12 (labeled with
Spectrum Green), deletion of 13q34 (Spectrum Aqua), and a
normal signal pattern for 13q14 (Spectrum Orange)
Discussion
Chronic lymphocytic leukemia is the most common
adult leukemia. Chromosomal aberrations are reported in
60% to 80% of CLL cases with the use of FISH 
5. Approxi-
mately half of patients show single abnormalities, a quarter
display two abnormalities, and the remaining cases demon-
strate complex chromosome changes 
1–3.
Trisomy 12 is reported more common in atypical B-
CLL than in the typical form and generally is considered as a
late event in the pathogenesis of B-CLL. This abnormality is
associated with poor prognosis 
1.
In this patient, two pathologic clones were identified:
one with monosomy 12 and one with monosomy 12 accom-
panied with deletion of 13q34. Since the aneuploidy of
13q34 region was not seen as a separate clone, it suggested
monosomy 12 as primary phenomenon.
The combination of monosomy 12 and deletion 13q34
had been reported previously only once, in the Case Re-
ports section of the Atlas of Genetics and Oncology 
6 in a
CLL patient with a t(1; 14; 6), as well as monosomy 6 and
marker chromosomes. The author demonstrated that the
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cluded that the 14q32 rearrangement was a clinically rele-
vant abnormality, while the exact significance of mono-
somy 12 and 13q34 deletion remained unknown. Several
genes, possibly relevant to B-cell proliferation, including
those coding for insulin-like growth factor-1, stem cell
factor, as well as the murine double minute-2 (MDM2)
gene and the B-cell leukemia/lymphoma 7 (BCL7) onco-
gene, were mapped to chromosome 12. Mainly, their role,
if any, in the pathogenesis of CLL remains obscure. A
small region at 12q13–15, that contains the murine double
minute-2 gene (MDM-2) was indicated as possibly relevant
in the pathogenesis of CLL, and overexpression of MDM-2
was identified in patients with aggressive disease 
1, 7. Sev-
eral regions of chromosome arm 13q are detected where
tumor-suppressor genes inactivated in head-and-neck
squamous cell carcinomas may be located. One such candi-
date within 13q34 is the ING1 putative tumor-suppressor
gene. The ING1 protein (p33) is thought to be a component
of the p53 signaling pathway 
8, 9.
In non-small cell lung cancer chromosomal abnormali-
ties are complex. Frequent losses of 3p, 6q, 8p, 9p, 9q, 13q,
17p, 18q, 19p, 21q and 22q have been reported while gains
of 1p, 1q, 3q, 5p, 7p, 7q, 8q, 11q and 12q have also been
common 
10.
Conclusion
Simultaneous occurence of monosomy 12 and 13q34
deletion in a patient with B-cell chronic lymphocytic leuke-
mia was described second time, but here as the only aberra-
tions in a patient’s karyotype. The prognostic significance
and underlying pathogenetic event(s) remain unknown.
However, karyotypic complexity is an adverse prognostic in-
dicator in a patient with CLL. To our knowledge, the present
case is unique, with no similar case reported to date. The in-
cidence and prognostic significance of this karyotypic evo-
lution is difficult to assess and studies of similar cases may
give additional insight into this interesting observation.
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